Viropin Pharmaceutical Revenue

Biotechnology Research • Dunedin, Otago, New Zealand • 1-10 Employees

Viropin Pharmaceutical revenue & valuation

Annual revenue	$342,220
Revenue per employee	$86,000
Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues	$1,100,000
Total funding	No funding

Key Contact at Viropin Pharmaceutical

Anna Campbell

Chief Executive Officer & Co Founder

Company overview

Headquarters	8 Stafford St, Dunedin, Otago 9016, NZ
Website	viropin.com
NAICS	541714
Founded	2024
Employees	1-10

Viropin Pharmaceutical Email Formats

Viropin Pharmaceutical uses 1 email format. The most common is {first initial}.{last name} (e.g., j.doe@viropin.com), used 100% of the time.

Format	Example	Percentage
{first initial}.{last name}	j.doe@viropin.com	100%

About Viropin Pharmaceutical

Viropin's Mission is to pioneer a future where infectious diseases are anticipated and neutralised before they threaten humanity. The world is on the verge of a microbial apocalypse with the rise in drug-resistant microbes. Viropin has a 3-prong approach to disease control: 1. Surveillance via proprietary AI tech. 2. Diagnostics via VariantVault, a cutting-edge microbe library. 3. Treatment of drug-resistant microbes with proprietary sterilants, decolonizers and anti-viral products.

Employees by Management Level

Total employees: 1-10

Seniority

Employees

Founder/Owner

Employees by Department

Viropin Pharmaceutical has 1 employees across 1 departments.

Departments

Number of employees

Funding Data

Viropin Pharmaceutical has never raised funding before.

Frequently asked questions

Viropin Pharmaceutical is located in Dunedin, Otago, NZ.

Viropin Pharmaceutical generates an estimated annual revenue of $342,220. This revenue figure reflects the company's market position and business performance in its industry.

Viropin Pharmaceutical has an estimated valuation of $1,100,000. This valuation is calculated based on industry-standard revenue multiples and reflects the company's growth potential and market positioning.

Viropin Pharmaceutical was founded in 2024, making it 2 years old. The company has established itself as a significant player in its industry over this time.

Viropin Pharmaceutical has approximately 1-10 employees. The company continues to grow its workforce to support its business operations and expansion.

Key Contact at Viropin Pharmaceutical

Anna Campbell

Chief Executive Officer & Co Founder

4.8

40,000 users